MicroRNAs as Multifaceted Players in Glioblastoma Multiforme.

Authors: Mercatelli N, Galardi S, Ciafrè SA Abstract Glioblastoma multiforme (GBM) is the most common and inevitably lethal primary brain tumor, with a median survival rate of only 15 months from diagnosis. The current standard treatment involves maximal surgical resection flanked by radiotherapy and chemotherapy with the alkylating agent temozolomide. However, even such aggressive treatment is never curative, and recurrent tumors always arise, commonly in more aggressive, chemo- and radio-resistant forms, leading to untreatable and deadly tumors. MicroRNAs, recognized major players in cancer, are deeply involved in GBM, as shown by more than a decade of studies. In this review, we revise the main milestones of MicroRNA studies in GBM, and the latest relevant discoveries in this f...

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2gSGCXz
via IFTTT